201 related articles for article (PubMed ID: 24628623)
1. Combined melanocytic and sweat gland neoplasm: cell subsets harbor an identical HRAS mutation in phacomatosis pigmentokeratotica.
Li JY; Berger MF; Marghoob A; Bhanot UK; Toyohara JP; Pulitzer MP
J Cutan Pathol; 2014 Aug; 41(8):663-71. PubMed ID: 24628623
[TBL] [Abstract][Full Text] [Related]
2. Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell.
Groesser L; Herschberger E; Sagrera A; Shwayder T; Flux K; Ehmann L; Wollenberg A; Torrelo A; Bagazgoitia L; Diaz-Ley B; Tinschert S; Oschlies I; Singer S; Mickler M; Toll A; Landthaler M; Real FX; Hafner C
J Invest Dermatol; 2013 Aug; 133(8):1998-2003. PubMed ID: 23337891
[TBL] [Abstract][Full Text] [Related]
3. The first case of Chinese phacomatosis pigmentokeratotica diagnosed by a missense HRAS mosaicism.
Huang L; Zhang J; Chen F; Zhang X; Cao Y; Cheng R; Deng D
J Dermatol; 2022 Sep; 49(9):921-924. PubMed ID: 35567308
[TBL] [Abstract][Full Text] [Related]
4. Phacomatosis Pigmentokeratotica: A Mosaic RASopathy with Malignant Potential.
Om A; Cathey SS; Gathings RM; Hudspeth M; Lee JA; Marzolf S; Wine Lee L
Pediatr Dermatol; 2017 May; 34(3):352-355. PubMed ID: 28523882
[TBL] [Abstract][Full Text] [Related]
5. Phacomatosis pigmentokeratotica: a case of HRAS mosaicism causing rhabdomyosarcoma.
Prieto-Barrios M; Llamas-Martin R; Velasco-Tamariz V; Calleja-Algarra A; Ruano Y; Ortiz-Romero PL; Rodriguez-Peralto JL
Br J Dermatol; 2018 Nov; 179(5):1163-1167. PubMed ID: 29430633
[TBL] [Abstract][Full Text] [Related]
6. Phacomatosis pigmentokeratotica is a "pseudodidymosis".
Happle R
J Invest Dermatol; 2013 Aug; 133(8):1923-5. PubMed ID: 23856930
[TBL] [Abstract][Full Text] [Related]
7. Activating HRAS mutation in agminated Spitz nevi arising in a nevus spilus.
Sarin KY; Sun BK; Bangs CD; Cherry A; Swetter SM; Kim J; Khavari PA
JAMA Dermatol; 2013 Sep; 149(9):1077-81. PubMed ID: 23884457
[TBL] [Abstract][Full Text] [Related]
8. Genomic analysis of a case of agminated Spitz nevi and congenital-pattern nevi arising in extensive nevus spilus.
Porubsky C; Teer JK; Zhang Y; Deschaine M; Sondak VK; Messina JL
J Cutan Pathol; 2018 Feb; 45(2):180-183. PubMed ID: 29210482
[TBL] [Abstract][Full Text] [Related]
9. HRAS mutation in phacomatosis pigmentokeratotica without extracutaneous disease.
Jennings L; Cummins R; Murphy GM; Gulmann C; O'Kane M
Clin Exp Dermatol; 2017 Oct; 42(7):791-792. PubMed ID: 28736904
[No Abstract] [Full Text] [Related]
10. Massively parallel sequencing analysis of benign melanocytic naevi.
Lozada JR; Geyer FC; Selenica P; Brown D; Alemar B; Merghoub T; Berger MF; Busam KJ; Halpern AC; Weigelt B; Reis-Filho JS; Hollmann TJ
Histopathology; 2019 Jul; 75(1):29-38. PubMed ID: 30791119
[TBL] [Abstract][Full Text] [Related]
11. Phacomatosis pigmentokeratotica and precocious puberty associated with HRAS mutation.
Martin RJ; Arefi M; Splitt M; Redford L; Moss C; Rajan N
Br J Dermatol; 2018 Jan; 178(1):289-291. PubMed ID: 28489335
[No Abstract] [Full Text] [Related]
12. Phacomatosis pigmentokeratotica: a further case without extracutaneous anomalies and review of the condition.
Chantorn R; Shwayder T
Pediatr Dermatol; 2011; 28(6):715-719. PubMed ID: 22082467
[TBL] [Abstract][Full Text] [Related]
13. Phacomatosis pigmentokeratotica: Postzygotic HRAS mutation with malignant degeneration of the sebaceous naevus.
Cranwell WC; Walsh M; Winship I
Australas J Dermatol; 2019 Aug; 60(3):e245-e246. PubMed ID: 30767209
[No Abstract] [Full Text] [Related]
14. Identification of HRAS mutations and absence of GNAQ or GNA11 mutations in deep penetrating nevi.
Bender RP; McGinniss MJ; Esmay P; Velazquez EF; Reimann JD
Mod Pathol; 2013 Oct; 26(10):1320-8. PubMed ID: 23599145
[TBL] [Abstract][Full Text] [Related]
15. Phacomatosis pigmentokeratotica: speckled-lentiginous nevus in association with nevus sebaceus.
Langenbach N; Hohenleutner U; Landthaler M
Dermatology; 1998; 197(4):377-80. PubMed ID: 9873178
[TBL] [Abstract][Full Text] [Related]
16. Phacomatosis pigmentokeratotica: a patient with the rare melanocytic-epidermal twin nevus syndrome.
Hermes B; Cremer B; Happle R; Henz BM
Dermatology; 1997; 194(1):77-9. PubMed ID: 9031800
[TBL] [Abstract][Full Text] [Related]
17. Genetic alterations in melanocytic tumors.
Takata M; Saida T
J Dermatol Sci; 2006 Jul; 43(1):1-10. PubMed ID: 16750612
[TBL] [Abstract][Full Text] [Related]
18. Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia.
Lim YH; Ovejero D; Sugarman JS; Deklotz CM; Maruri A; Eichenfield LF; Kelley PK; Jüppner H; Gottschalk M; Tifft CJ; Gafni RI; Boyce AM; Cowen EW; Bhattacharyya N; Guthrie LC; Gahl WA; Golas G; Loring EC; Overton JD; Mane SM; Lifton RP; Levy ML; Collins MT; Choate KA
Hum Mol Genet; 2014 Jan; 23(2):397-407. PubMed ID: 24006476
[TBL] [Abstract][Full Text] [Related]
19. Proliferative nodules arising within congenital melanocytic nevi: a histologic, immunohistochemical, and molecular analyses of 43 cases.
Phadke PA; Rakheja D; Le LP; Selim MA; Kapur P; Davis A; Mihm MC; Hoang MP
Am J Surg Pathol; 2011 May; 35(5):656-69. PubMed ID: 21436676
[TBL] [Abstract][Full Text] [Related]
20. Phacomatosis pigmentokeratotica: report of new cases and further delineation of the syndrome.
Tadini G; Restano L; Gonzáles-Pérez R; Gonzáles-Enseñat A; Vincente-Villa MA; Cambiaghi S; Marchettini P; Mastrangelo M; Happle R
Arch Dermatol; 1998 Mar; 134(3):333-7. PubMed ID: 9580120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
